QIAcuity digital PCR now offers ability for simultaneous detection of up to 12 targets from one biological sample, a more than two-fold increase from prior capability for up to five targets No instrument hardware changes required for upgraded capability thanks to new QIAcuity Software 3.1 update and launch of QIAcuity High Multiplex Probe PCR Kit […]
UK Biobank Pharma Proteomics Project aims to create a comprehensive map of disease-associated protein levels in the human body to advance biomarker discovery WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the UK Biobank Pharma Proteomics Project (UKB-PPP) has selected its Olink® Explore Platform to support the […]
MINNEAPOLIS — Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of new designer proteins engineered using advanced Artificial Intelligence (AI) based design platforms and protein evolutionary workflows. This expanded portfolio from Bio-Techne’s R&D Systems brand includes IL-2 Heat Stable Agonist, Activin A Hyperactive, FGF basic Heat Stable (available […]
MENLO PARK, Calif. — PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and Intus Bio, a leader in microbiome research and discovery, today unveiled GutID, the first commercial human gut health test powered by Intus Bio’s groundbreaking Titan-1 platform and PacBio’s HiFi sequencing technology. By combining Intus Bio’s patented strain-level resolution assay […]
Complementary offerings will accelerate translation of biomarkers from research to the clinic driving new growth Expanded customer relationships and continuum of solution offerings maximize cross-selling opportunities across translational, academic and pharma applications Expects to generate approximately $40 million of annual cost synergies by the end of 2026 with path to positive free cash flow generation in 2026 […]
Viral vector service expansion empowers scientists by offering high-quality research reagents through on-demand AAV production from Addgene’s vast plasmid repository WATERTOWN, Mass. — Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed and reproducibility, today announced the expansion of its viral vector service with Packaged on Request. Customers can now select an […]
Key Points: Esco Aster and Esco Lifesciences Group introduce the world’s first closed single-use bioreactor system, designed to meet Human and Animal Biosafety Levels (BSL) 3/4 standards for the safe culture of high-risk viruses, ensuring enhanced biosafety and containment during bioprocessing. The CelCradle® + system plays a vital role in enhancing vaccine self-sufficiency, especially in […]
Simon Egli Appointed Chief Executive Officer as Co-Founder Pascal Behr Transitions to Board of Directors Zürich, Switzerland – Cytosurge AG, a leader in single-cell manipulation, a biotech company pioneering innovative single-cell biopsies and cell-line engineering solutions, announces a leadership transition effective January 1, 2025. Pascal Behr, Ph.D., co-founder and CEO for 12 years, remains on the […]
ATCC will provide lab services including immunological and virological assays, and reagent and viral stock preparation to support the Animal Models and Retroviral Vaccines Section within the National Cancer Institute’s Vaccine Branch MANASSAS, Va. — ATCC, the world’s premier biological materials management and standards organization, today announced that it has been awarded a five-year, Indefinite […]
Powered by Elegen’s patented cell-free linear DNA synthesis technology, ENFINIA™ Plasmid DNA slashes lead times from months to weeks at an affordable price. SAN CARLOS, Calif. – Elegen, the leader in next-generation DNA manufacturing, today announced the launch of ENFINIA™ Plasmid DNA, a faster, cost-effective solution for clonal synthesis of long and complex genes. ENFINIA Plasmid […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
